14/03/2022 - 13:14

Memphasys achieves critical accreditation for key markets

14/03/2022 - 13:14

Bookmark

Save articles for future reference.

Trailblazing biotech Memphasys has achieved a crucial step in the rollout of its IVF sperm separation technology after winning a draft ISO for its quality management system for manufacturing medical devices. Memphasys said the ISO 13485 certificate will assist with selling medical devices in high regulatory markets such as Australia, Europe and China and it is an important step for product accreditation and acceptance by customers.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options